Martine Zimmermann

Director/Board Member at LIGAND PHARMACEUTICALS INCORPORATED

Net worth: 1 M $ as of 2026-05-30

57 year

Health Technology

Consumer Services

Profile

Martine Zimmermann currently works at Ligand Pharmaceuticals, Inc., as Independent Director from 2023 and Inventiva SA, as EVP-Regulatory Affairs & Quality Assurance from 2025.
Dr. Zimmermann also formerly worked at Caelum Biosciences, Inc., as Director from 2019 to 2021, Alexion Pharmaceuticals, Inc., as Senior VP & Head-Global Regulatory Affairs from 2016 to 2023, and Ipsen Biopharmaceuticals, Inc., as SVP, Head-Regulatory Affairs, R&D Quality.
Dr. Zimmermann received her doctorate degree from the University of Strasbourg and doctorate degree from Louis Pasteur University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LIGAND PHARMACEUTICALS INCORPORATED 0.03%	2026-06-04	5,097 ( 0.03% )	1 M $	2026-05-30

Martine Zimmermann active positions

Companies	Position	Start
INVENTIVA	General Counsel	2025-07-08
LIGAND PHARMACEUTICALS INCORPORATED	Director/Board Member	2023-09-25

All active positions of Martine Zimmermann

Former positions of Martine Zimmermann

Companies	Position	End
ALEXION PHARMACEUTICALS, INC.	General Counsel	2023-01-31
Caelum Biosciences, Inc. Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders	Director/Board Member	2020-12-31
Ipsen Biopharmaceuticals, Inc. Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company	General Counsel	-

See the detail of Martine Zimmermann's experience

Training of Martine Zimmermann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martine Zimmermann's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Ligand Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders	Health Technology
University of Strasbourg University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ipsen Biopharmaceuticals, Inc. Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company	Health Technology
Inventiva SA Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases	Health Technology
Caelum Biosciences, Inc. Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders	Health Technology
Louis Pasteur University Louis Pasteur University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services